Pages tagged with: itsmed
-
University spin-out company to develop new antibiotics
New University of Plymouth spinout company Amprologix has been established to help tackle the problem of antibiotic resistance – by developing new antibiotics and bringing them to market. It is led by Professor Mat Upton in collaboration with Frontier IP
-
ITSMed research
University of Plymouth Institute of Translational and Stratified Medicine (ITSMed) research. World-class translational, collaborative, interdisciplinary laboratory, clinical and applied health research for patient and public benefit.
-
Dementia screening app shortlisted for two national awards
ACEmobile, a dementia screening app developed by Dr Craig Newman from the University of Plymouth and Dr Rupert Noad and University Hospitals Plymouth NHS Trust, has made the final of two categories at the HSJ Awards.
-
3D bioprinter revolutionises skin research
A new piece of technology at the University of Plymouth is helping researchers develop a working skin substitute. The 3D bioprinter will enable the team to test whether extracts from native Cornish plants and seaweeds have powerful skin-care applications.
-
Publications and resources
Research publications, annual reports and brochures from ITSMed.
-
Our research funders
University of Plymouth research: Institute of Translational and Stratified Medicine (ITSMED) our research partners.
-
ITSMed projects
Key current translational and stratified medicine projects at the University of Plymouth.
-
Epilepsy monitoring app leads the way for NHS70
EpSMon, an app developed by a team of partners, including Dr Craig Newman from the University of Plymouth that helps people with epilepsy manage their condition, has been chosen by the NHS to celebrate digital innovation within healthcare.
-
Denis rides again – charity cycle for life-saving medical research
Denis Wilkins, Chair of Peninsula Medical Foundation, is cycling the length of the UK to support research in the University's Institute of Translational and Stratified Medicine
-
Research grant to develop vaccine for mastitis in cows
University spinout company The Vaccine Group (TVG), led by Dr Michael Jarvis, has received £50,000 from the global Bacterial Vaccine Network (“BactiVac”) and will use the grant to run a proof-of-concept study
-
£2 million research funding to address chronic lung disease in developing world
The University of Plymouth is part of a £2 million project to address chronic lung disease in the developing world through pulmonary (lung-related) rehabilitation.
-
Our research partners
University of Plymouth research: Our research partners - From advancing technology to direct impact on patient care our research partnerships are at the heart of ITSMed’s approach to research